Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study

INTRODUCTION: Immune checkpoint inhibitors (ICIs) have demonstrated promising efficacy as monotherapy in patients with pulmonary sarcomatoid carcinoma (PSC). We performed the current multi-institutional, real-world study to assess the efficacy of ICIs plus chemotherapy in patients with PSC. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fei, Guo, Haoyue, Zhou, Xiaolong, Xie, Huikang, Tian, Tian, Zhao, Wencheng, Gao, Guanghui, Xiong, Anwen, Wang, Lei, Li, Wei, Chen, Xiaoxia, Zhang, Yan, Fan, Jue, Wu, Fengying, Zhang, Yongchang, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Immunotherapy for Lung Cancer: Progress, Opportunities and Challenges
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676284/
https://www.ncbi.nlm.nih.gov/pubmed/36419724
http://dx.doi.org/10.1177/17588359221136759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676284/
https://www.ncbi.nlm.nih.gov/pubmed/36419724
http://dx.doi.org/10.1177/17588359221136759

Ejemplares similares